Project Details
Project Description
Monash Health Ref: RES-18-0000-484A
| Status | Active |
|---|---|
| Effective start/end date | 16/11/18 → 15/11/23 |
A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sitravatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors
- Markman, Ben (Chief Investigator (CI))
- Day, Daphne (Primary Chief Investigator (PCI))
Project: Research